Binimetinib
Brand name: Mektovi
Rank #494 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$14.1M
Total Cost
1,094
Total Claims
$14.1M
Total Cost
62
Prescribers
$13K
Cost per Claim
0
Beneficiaries
1,098
30-Day Fills
$228K
Avg Cost/Provider
18
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$14.1M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $14.1M total
🔎 Data Overview
At $12,916 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $227,909 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Binimetinib
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Riley Fadden | Nurse Practitioner | Boston, MA | 44 | $745K |
| 2 | Paul Chapman | Medical Oncology | New York, NY | 33 | $476K |
| 3 | Aimee Kohn | Medical Oncology | Portland, OR | 30 | $449K |
| 4 | Douglas Johnson | Medical Oncology | Nashville, TN | 38 | $417K |
| 5 | Michele Nanni | Physician Assistant | Buffalo, NY | 29 | $416K |
| 6 | Jason Chesney | Hematology-Oncology | Louisville, KY | 29 | $409K |
| 7 | Isabella Glitza | Internal Medicine | Houston, TX | 25 | $375K |
| 8 | Matthew Block | Medical Oncology | Rochester, MN | 30 | $350K |
| 9 | Matthew Taylor | Medical Oncology | Portland, OR | 31 | $333K |
| 10 | Amit Arora | Hematology-Oncology | Fremont, CA | 26 | $324K |
| 11 | Michele Freesmeier | Physician Assistant | Iowa City, IA | 32 | $320K |
| 12 | Svetomir Markovic | Medical Oncology | Rochester, MN | 21 | $312K |
| 13 | Harpaul Gill | Hematology-Oncology | Alpharetta, GA | 19 | $299K |
| 14 | Lalit Aneja | Hematology-Oncology | Venice, FL | 20 | $298K |
| 15 | Adi Diab | Medical Oncology | Houston, TX | 23 | $296K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 491 | Ozanimod Hydrochloride (Zeposia) | $14.2M | 1,535 |
| 492 | Enoxaparin Sodium (Enoxaparin Sodium) | $14.2M | 93,202 |
| 493 | Omadacycline Tosylate (Nuzyra) | $14.1M | 1,395 |
| 494 | Binimetinib (Mektovi) | $14.1M | 1,094 |
| 495 | Glecaprevir/Pibrentasvir (Mavyret) | $14.1M | 1,011 |
| 496 | Pacritinib Citrate (Vonjo) | $13.9M | 626 |
| 497 | Olmesartan/Hydrochlorothiazide (Olmesartan-Hydrochlorothiazide) | $13.9M | 246,637 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology